Dr Hendrik Falk
Director, Discovery Technology
Dr Hendrik Falk was awarded a B.A. in Business Information Technology and then studied pharmacy at the Martin-Luther Universität Halle/ Germany, receiving the licence to practise in 2000. During his doctoral thesis at the Freie Universität Berlin, Dr Falk examined the involvement of G proteins in cellular signalling. During post-doctoral studies in the Molecular Tumour Genetics group at the Max-Delbrück-Center, Berlin/ Germany, Dr Falk expanded his skills to the high-throughput screening for ligands of G protein coupled receptors. Hendrik brings extensive knowledge in molecular biology as well as biochemical and cellular assays of mammalian cells to the HTCS.
Dr Falk joined the HTCS group as a Research Officer in 2008. He is responsible for designing, developing and implementing high throughput screens and follow-up studies in collaboration with the sponsoring research group. His responsibilities predominantly include providing assay/database support for the Co-operative Research Centre for Cancer Therapeutics projects.